Authors: Kim, Se Min¹ (AUTHOR), Park, Namu² (AUTHOR), Park, Hye Bin³ (AUTHOR), Lee, JuKyung³ (AUTHOR), Chun, Changho^4,5 (AUTHOR), Kim, Kyung Hoon⁴ (AUTHOR), Choi, Jong Seob⁶ (AUTHOR), Kim, Hyung Jin⁷ (AUTHOR), Choi, Sekyu⁸ (AUTHOR), Lee, Jung Hyun^9,10 (AUTHOR) jlee24@uw.edu

Superior Title: PLoS ONE. 5/14/2024, Vol. 19 Issue 5, p1-16. 16p.

Subject Terms: *IMMUNOGLOBULIN genes, *IMMUNE checkpoint inhibitors, *TRIPLE-negative breast cancer, *IMMUNOTHERAPY, *BIOMARKERS, *GENE families

Authors: Wang, Min¹ (AUTHOR), Jing, Xuquan¹ (AUTHOR), Chen, Feihu¹ (AUTHOR), Lu, Shuangqing¹ (AUTHOR), Sun, Yulan² (AUTHOR) 306920775@qq.com

Superior Title: BMC Cancer. 5/7/2024, Vol. 24 Issue 1, p1-13. 13p.

Subject Terms: *IMMUNE checkpoint inhibitors, *NON-small-cell lung carcinoma, *IMMUNOTHERAPY

Authors: Kong, Ying¹ (AUTHOR), Hong, Liang¹ (AUTHOR) kongying1504@163.com, Xu, Xiao-cheng¹ (AUTHOR), Chen, Yun-feng² (AUTHOR), Xu, Jia¹ (AUTHOR)

Superior Title: PLoS ONE. 4/29/2024, Vol. 19 Issue 4, p1-19. 19p.

Subject Terms: *IMMUNE checkpoint inhibitors, *CLINICAL trials, *LUNG cancer, *PNEUMONIA, *NON-small-cell lung carcinoma, *PROGRESSION-free survival

Authors: Bendixen, Kamilla Kolding¹ (AUTHOR), Forsberg-Pho, Sofie¹ (AUTHOR), Dazio, Giulia² (AUTHOR), Hansen, Emeli Elisabeth¹ (AUTHOR), Eriksen, Sarah Kronborg¹ (AUTHOR), Epistolio, Samantha² (AUTHOR), Merlo, Elisabetta² (AUTHOR), Boldorini, Renzo³ (AUTHOR), Venesio, Tiziana⁴ (AUTHOR), Movilia, Alessandra⁵ (AUTHOR), Caprera, Cecilia⁶ (AUTHOR), Arnspang, Eva Christensen⁷ (AUTHOR), Børgesen, Michael¹ (AUTHOR), Christensen, Ulf Bech¹ (AUTHOR), Frattini, Milo² (AUTHOR), Petersen, Rasmus Koefoed¹ (AUTHOR) rkp@pentabase.com

Superior Title: PLoS ONE. 4/25/2024, Vol. 19 Issue 4, p1-18. 18p.

Subject Terms: *IMMUNE checkpoint inhibitors, *NUCLEIC acid isolation methods, *MICROSATELLITE repeats, *CAPILLARY electrophoresis, *DISEASE progression, *MELTING

Authors: Liu, Xin¹ (AUTHOR), Li, Su² (AUTHOR), Ke, Liyuan² (AUTHOR), Cui, Hongxia² (AUTHOR) 15940166854@163.com

Superior Title: BMC Cancer. 4/17/2024, Vol. 24 Issue 1, p1-14. 14p.

Subject Terms: *IMMUNE checkpoint inhibitors, *AUTOIMMUNE diseases, *CANCER patients, *IPILIMUMAB, *SCIENCE databases, *WEB databases

Authors: Hulo, Pauline^1,2 (AUTHOR), Deshayes, Sophie¹ (AUTHOR), Fresquet, Judith¹ (AUTHOR), Chéné, Anne-Laure^1,3 (AUTHOR), Blandin, Stéphanie⁴ (AUTHOR), Boisgerault, Nicolas¹ (AUTHOR), Fonteneau, Jean-François¹ (AUTHOR), Treps, Lucas¹ (AUTHOR), Denis, Marc G^1,5 (AUTHOR), Bennouna, Jaafar^1,2 (AUTHOR), Fradin, Delphine¹ (AUTHOR), Pons-Tostivint, Elvire^1,2 (AUTHOR) elvire.pons@chu-nantes.fr, Blanquart, Christophe¹ (AUTHOR) christophe.blanquart@inserm.fr

Superior Title: Respiratory Research. 4/5/2024, Vol. 25 Issue 1, p1-14. 14p.

Subject Terms: *NON-small-cell lung carcinoma, *IMMUNE checkpoint inhibitors, *CELL cycle, *CANCER chemotherapy, *LUNG cancer

Authors: Mao, Yun‐tao¹ (AUTHOR), Wang, Ying^1,2 (AUTHOR), Chen, Xiao‐Xiao¹ (AUTHOR), Liu, Cheng‐jiang³ (AUTHOR), Bao, Qi⁴ (AUTHOR) baoqi@zju.edu.cn

Superior Title: Journal of Cosmetic Dermatology. Apr2024, Vol. 23 Issue 4, p1165-1177. 13p.

Subject Terms: *IPILIMUMAB, *IMMUNE checkpoint inhibitors, *DRUG side effects, *CLINICAL trials, *NIVOLUMAB, *MELANOMA

Authors: Lai, Gu-Shun^1,2 (AUTHOR), Li, Jian-Ri^1,2,3 (AUTHOR), Wang, Shian-Shiang^1,2,4 (AUTHOR), Chen, Chuan-Shu^1,2 (AUTHOR), Yang, Chun-Kuang^1,2 (AUTHOR), Lin, Chia-Yen^1,2 (AUTHOR), Hung, Sheng-Chun^1,2 (AUTHOR), Chiu, Kun-Yuan^1,2,4 (AUTHOR), Yang, Shun-Fa^1,5 (AUTHOR) ysf@csmu.edu.tw

Superior Title: PLoS ONE. 3/28/2024, Vol. 19 Issue 3, p1-11. 11p.

Subject Terms: *RENAL cell carcinoma, *IMMUNE checkpoint inhibitors, *CELL analysis, *NEPHRECTOMY, *DATABASES, *BREAST

Authors: Hou, Changlong^1,2 (AUTHOR) houchanglong2022@126.com, Xiong, Baizhu^1,2 (AUTHOR), Zhou, Lei¹ (AUTHOR), Fei, Yipeng¹ (AUTHOR), Shi, Changgao¹ (AUTHOR), Zhu, Xianhai¹ (AUTHOR), Xie, Tao¹ (AUTHOR), Wu, Yulin^1,2 (AUTHOR)

Superior Title: BMC Cancer. 3/27/2024, Vol. 24 Issue 1, p1-12. 12p.

Subject Terms: *CHEMOEMBOLIZATION, *IMMUNE checkpoint inhibitors, *LIVER cancer, *PROGNOSIS, *PORTAL vein, *HEPATOCELLULAR carcinoma

Authors: Sakuragi, Minoru^1,2 (AUTHOR), Uchino, Eiichiro^1,2 (AUTHOR), Sato, Noriaki^1,2 (AUTHOR), Matsubara, Takeshi² (AUTHOR), Ueda, Akihiko^1,3 (AUTHOR), Mineharu, Yohei^1,4,5 (AUTHOR), Kojima, Ryosuke¹ (AUTHOR), Yanagita, Motoko^2,6 (AUTHOR) okuno.yasushi.4c@kyoto-u.ac.jp, Okuno, Yasushi¹ (AUTHOR) okuno.yasushi.4c@kyoto-u.ac.jp

Superior Title: PLoS ONE. 3/19/2024, Vol. 19 Issue 3, p1-14. 14p.

Subject Terms: *IMMUNE checkpoint inhibitors, *ACUTE kidney failure, *MACHINE learning, *IMMUNE checkpoint proteins, *RECEIVER operating characteristic curves, *SUMATRIPTAN

Authors: Zhang, Jingjing¹ (AUTHOR), Wang, Lei² (AUTHOR), Zhang, Shasha¹ (AUTHOR), Cao, Ruijie¹ (AUTHOR), Zhao, Yufei¹ (AUTHOR), Zhao, Yue¹ (AUTHOR), Song, Yanrong³ (AUTHOR), Guo, Zhanjun¹ (AUTHOR) zjguo5886@aliyun.com

Superior Title: BMC Cancer. 2/26/2024, Vol. 24 Issue 1, p1-9. 9p.

Subject Terms: *IMMUNE checkpoint inhibitors, *ALPHA fetoproteins, *TREATMENT effectiveness, *STOMACH cancer, *CANCER patients, *PROPENSITY score matching

Authors: Lim, Sung Hee^1,2 (AUTHOR), Lee, Keun-Wook³ (AUTHOR) imdoctor@snu.ac.kr, Kim, Jae-Joon⁴ (AUTHOR), Im, Hyeon-Su⁵ (AUTHOR), Kim, In-Ho⁶ (AUTHOR), Han, Hye Sook⁷ (AUTHOR), Koo, Dong-Hoe⁸ (AUTHOR), Cho, Jang Ho⁹ (AUTHOR), Maeng, Chi Hoon¹⁰ (AUTHOR), Lee, Min-Young¹¹ (AUTHOR), Lee, Hyo Jin¹² (AUTHOR), Kim, Jwa Hoon¹³ (AUTHOR), Park, Sang Gon¹⁴ (AUTHOR), Jung, Joo Young¹⁵ (AUTHOR), Shin, Seong-Hoon¹⁶ (AUTHOR), Kim, Ki Hyang¹⁷ (AUTHOR), Kim, Hyeyeong⁵ (AUTHOR), Oh, So Yeon⁴ (AUTHOR), Kang, Minsu³ (AUTHOR), Jung, Minkyu¹⁸ (AUTHOR)

Superior Title: BMC Cancer. 2/23/2024, Vol. 24 Issue 1, p1-12. 12p.

Subject Terms: *IMMUNE checkpoint inhibitors, *CANCER patients, *PACLITAXEL, *IPILIMUMAB, *CANCER chemotherapy, *PROGRESSION-free survival, *SERUM albumin

Geographic Terms: SOUTH Korea

Authors: Dupain, Célia¹ (AUTHOR), Gutman, Tom² (AUTHOR), Girard, Elodie² (AUTHOR), Kamoun, Choumouss² (AUTHOR), Marret, Grégoire¹ (AUTHOR), Castel-Ajgal, Zahra¹ (AUTHOR), Sablin, Marie-Paule¹ (AUTHOR), Neuzillet, Cindy³ (AUTHOR), Borcoman, Edith¹ (AUTHOR), Hescot, Ségolène¹ (AUTHOR), Callens, Céline⁴ (AUTHOR), Trabelsi-Grati, Olfa⁴ (AUTHOR), Melaabi, Samia⁴ (AUTHOR), Vibert, Roseline⁴ (AUTHOR), Antonio, Samantha⁴ (AUTHOR), Franck, Coralie⁴ (AUTHOR), Galut, Michèle⁵ (AUTHOR), Guillou, Isabelle¹ (AUTHOR), Halladjian, Maral¹ (AUTHOR), Allory, Yves⁶ (AUTHOR)

Superior Title: BMC Biology. 2/20/2024, Vol. 22 Issue 1, p1-12. 12p.

Subject Terms: *IMMUNE checkpoint inhibitors, *LUNGS, *ENDOMETRIUM, *NUCLEOTIDE sequencing, *GENE frequency, *BIOINFORMATICS, *TUMORS

Company/Entity: UNITED States. Food & Drug Administration

Authors: Xie, Tianlei^1,2 (AUTHOR), Peng, Shan³ (AUTHOR), Liu, Shujun¹ (AUTHOR), Zheng, Minghao⁴ (AUTHOR), Diao, Wenli¹ (AUTHOR), Ding, Meng¹ (AUTHOR), Fu, Yao³ (AUTHOR), Guo, Hongqian¹ (AUTHOR) dr.ghq@nju.edu.cn, Zhao, Wei⁵ (AUTHOR) zw198626520@126.com, Zhuang, Junlong^1,2 (AUTHOR) zhuangjl@njglyy.com

Superior Title: Molecular Cancer. 2/10/2024, Vol. 23 Issue 1, p1-21. 21p.

Subject Terms: *BLADDER cancer, *IMMUNE checkpoint inhibitors, *DISEASE progression, *IMMUNOTHERAPY, *PROGNOSIS, *TUMOR microenvironment

Authors: Yan, Ningning¹ (AUTHOR), Zhang, Huixian¹ (AUTHOR), Shen, Shujing² (AUTHOR), Guo, Sanxing¹ (AUTHOR) sanxing134@hotmail.com, Li, Xingya¹ (AUTHOR) lixingya0925@vip.163.com

Superior Title: BMC Cancer. 2/6/2024, Vol. 24 Issue 1, p1-9. 9p.

Subject Terms: *IMMUNE checkpoint inhibitors, *PROGRAMMED death-ligand 1, *NON-small-cell lung carcinoma, *LUNG cancer, *IPILIMUMAB, *IMMUNE response

Authors: Caraban, Bogdan Marian^1,2 (AUTHOR), Aschie, Mariana^2,3,4,5,6 (AUTHOR), Deacu, Mariana^2,3 (AUTHOR), Cozaru, Georgeta Camelia^6,7 (AUTHOR), Pundiche, Mihaela Butcaru^2,8 (AUTHOR), Orasanu, Cristian Ionut^2,3,6 (AUTHOR) critian.ionut@gmail.com, Voda, Raluca Ioana^2,3,6 (AUTHOR)

Superior Title: Clinics & Practice. Feb2024, Vol. 14 Issue 1, p214-241. 28p.

Subject Terms: *IMMUNE checkpoint inhibitors, *BLOCKCHAINS, *OVERALL survival, *CELLULAR immunity, *CELL growth, *MELANOMA

Authors: Gong, Bingxin^1,2 (AUTHOR), Guo, Yusheng^1,2 (AUTHOR), Li, Yi^1,2 (AUTHOR), Wang, Jing^1,2 (AUTHOR), Zhou, Guofeng^1,2 (AUTHOR), Chen, Yong-hao³ (AUTHOR), Nie, Tong^1,2 (AUTHOR), Yang, Ming^1,2 (AUTHOR), Luo, Kun^1,2 (AUTHOR), Zheng, Chuansheng^1,2 (AUTHOR), Pan, Feng^1,2 (AUTHOR), Liang, Bo^1,2 (AUTHOR) xiehelb@sina.com, Yang, Lian^1,2 (AUTHOR) yanglian@hust.edu.cn

Superior Title: BMC Medicine. 1/31/2024, Vol. 22, p1-13. 13p.

Subject Terms: *CORONARY artery calcification, *IMMUNE checkpoint inhibitors, *DISEASE risk factors, *IPILIMUMAB, *NON-small-cell lung carcinoma, *CARDIOVASCULAR diseases, *DISEASE progression

Authors: Sun, Dantong^1,2 (AUTHOR), Qian, Haili² (AUTHOR) qianhaili001@163.com, Li, Junling¹ (AUTHOR) lijunling@cicams.ac.cn, Xing, Puyuan¹ (AUTHOR) xingpuyuan@cicams.ac.cn

Superior Title: Journal of Biomedical Science. 1/29/2024, Vol. 31 Issue 1, p1-12. 12p.

Subject Terms: *IMMUNE checkpoint inhibitors, *IMMUNOTHERAPY, *TUMOR microenvironment, *IMMUNOLOGICAL tolerance

Authors: Wang, Jingting¹ (AUTHOR), Ma, Yan² (AUTHOR), Lin, Haishan¹ (AUTHOR), Wang, Jing¹ (AUTHOR) wangjing1981@ccmu.edu.cn, Cao, Bangwei¹ (AUTHOR) oncology@ccmu.edu.cn

Superior Title: BMC Immunology. 1/24/2024, Vol. 25 Issue 1, p1-13. 13p.

Subject Terms: *DRUG side effects, *IMMUNE checkpoint inhibitors, *CANCER patients, *NEUTROPHIL lymphocyte ratio, *BIOMARKERS, *IPILIMUMAB, *DEXAMETHASONE

Authors: Wang, Dong-Xu¹ (AUTHOR), Long, Jun-Yu² (AUTHOR), Li, Rui-Zhe¹ (AUTHOR), Zhang, Dao-Lin¹ (AUTHOR), Liu, Hui¹ (AUTHOR), Liu, Jingru³ (AUTHOR), Tian, Jin-Cheng¹ (AUTHOR), Li, Han¹ (AUTHOR), Liu, Jie³ (AUTHOR) linchuangliujie@163.com, Zhao, Hai-Tao² (AUTHOR) zhaoht@pumch.cn, Li, Tao¹ (AUTHOR) litao7706@163.com

Superior Title: Molecular Cancer. 1/16/2024, Vol. 23 Issue 1, p1-8. 8p.

Subject Terms: *IMMUNE checkpoint inhibitors, *TUMOR microenvironment, *IMMUNOREGULATION, *GENE families, *GENETIC mutation